Brief: Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results And Provides Corporate Update
08/08/2023 14:14
Aug 8 (Reuters) - Corbus Pharmaceuticals Holdings Inc
CRBP.O :
* CORBUS PHARMACEUTICALS REPORTS SECOND QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* CORBUS PHARMACEUTICALS HOLDINGS INC Q2 LOSS PER SHARE
$2.05
* CORBUS PHARMACEUTICALS HOLDINGS INC - CASH, CASH
EQUIVALENTS &
INVESTMENTS ON HAND AS OF JUNE 30, IS EXPECTED TO FUND OPERS
THROUGH Q2 OF 2024
Source text for Eikon: ID:nPn2m5586a
Further company coverage: CRBP.O
Recent news on Corbus Pharmaceuticals Holdings
See all newsU.S. STOCKS ON THE MOVE-PBF Energy, Crown Castle, Definium Therapeutics
U.S. STOCKS ON THE MOVE-PBF Energy, Crown Castle, Definium Therapeutics
U.S. STOCKS ON THE MOVE-AI stocks, energy companies, Johnson & Johnson
U.S. STOCKS ON THE MOVE-US energy stocks, Baldwin, Johnson & Johnson
Corbus gains on weight-loss data for obesity drug in early-stage study